Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The authors of this study proposed that patients with diabetic ketoacidosis could be treated safely in a non-ICU setting using repeated subcutaneous doses of insulin lispro, and performed a study comparing this treatment regimen with standard regular insulin therapy administered by continuous IV infusion within the ICU setting.

Subcutaneous Lispro Insulin for Diabetic Ketoacidosis